Advanced medicated nanomaterials that provide time- and target-specific drug release profiles are highly desired for efficacious drug delivery. In this study, a structural nanocomposite (P2) consisted of tamoxifen citrate (TC) and polyvinylpyrrolidone (PVP) (2:8, w:w) as core and shellac as shell was designed and fabricated using a modified coaxial electrospraying process. Shellac solution, which could not be converted into solid particles individually, was explored as a shell working fluid to encapsulate the core TC-PVP blending solution, which could be electrosprayed into solid particles (P1) all alone. SEM and TEM evaluations demonstrated that the quality of the core-shell particles P2 was higher than that of the monolithic particles P1 in terms of particle diameter, size distribution and number of satellites. XRD results suggested that TC was similarly present in an amorphous state in particles P1 and P2 due to its fine compatibility with PVP, which was verified through FTIR tests. In vitro dissolution experiments suggested that P2 could provide the designed drug colon-specific delayed release characteristics, passing through acidic conditions of pH2.0 dissolution media and freeing all of the loaded TC within 5min at pH7.4 dissolution media.
Materials & design – Elsevier
Published: Apr 5, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
It’s easy to organize your research with our built-in tools.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud